Opinion

Podcast: The regulatory interplay between medical devices and medicines in clinical trials - EU and U.S. focus (Part 1)

Published Date
Sep 22 2023
The regulatory frameworks for medicines and medical devices have historically grown up on separate tracks, but increasingly, medicines and medical devices are being used together in patients as drug device combinations, companion diagnostics and medical devices used in clinical trials.
Join Sapna Palla, Eda Zhuleku and Rafi Allos in part one of this podcast series to discuss the use of medical devices in clinical trials and the different perspectives between the EU and U.S., as well as the regulatory requirements that may apply
Content Disclaimer

This content was originally published by Allen & Overy before the A&O Shearman merger

Related capabilities

Advisory and regulatoryLife sciences and healthcarePharmaceuticals

Related people

Image

Eda Zhuleku

Counsel

Munich

Eda advises national and international companies on all kind of regulatory aspects in the Life Sciences sector. 
Image

Rafi Allos

Partner

London

Rafi specialises in life sciences patents litigation and advising clients on regulatory issues in the life sciences sector.